Beyond the Tumor: From Evidence to Action – Part 2

Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for Part 2 of this DoctoRx Unscripted conversation exploring how biology-based behavior change is redefining cancer care.In Part 2, Dr. Small hosts Arianna Huffington, Founder and CEO of Thrive Global, and Chris Boerner, Board Chair and CEO of Bristol Myers Squibb, for a candid discussion on moving beyond treating the tumor to delivering true whole-person care.Together, they explore:

How everyday factors, like sleep, stress, movement, and social connection, impact cancer care

Simple steps to reinforce healthier daily routines

Why lifestyle changes remain critical alongside medical therapies

How pharma leaders can integrate behavioral metrics into clinical trials

Strategies to overcome healthcare disparities and expand access to behavioral health tools

Medicines and healthy behaviors achieve more together than either can alone. Tune in to see why placing the patient at the center of oncology care can drive better long-term outcomes.